T1	chemical 0 11	Factor VIII
T2	chemical 20 27	antigen
T3	disease_or_phenotypic_feature 43 49	myxoma
T4	chemical 92 98	MART-1
T5	disease_or_phenotypic_feature 113 121	melanoma
T6	chemical 128 135	antigen
T7	disease_or_phenotypic_feature 220 236	Multiple myeloma
T8	chemical 268 275	biology
T9	chemical 313 323	surfactant
T10	chemical 332 338	oxygen
T11	chemical 420 426	oxygen
T12	disease_or_phenotypic_feature 494 507	breast cancer
T13	chemical 596 603	Alcohol
T14	chemical 631 634	met
T15	disease_or_phenotypic_feature 679 688	Disorders
T16	chemical 817 826	acridines
T17	disease_or_phenotypic_feature 869 876	one-pot
T18	chemical 928 937	aldehydes
T19	chemical 939 972	5,5-dimethyl-1,3-cyclohexanedione
T20	chemical 979 985	amines
T21	chemical 989 1006	ammonium acetates
T22	chemical 1048 1062	cobalt-alanine
T23	chemical 1063 1068	metal
T24	chemical 1091 1098	ethanol
T25	chemical 1179 1187	thrombin
T26	chemical 1188 1197	inhibitor
T27	disease_or_phenotypic_feature 1248 1265	cerebral ischemia
T28	disease_or_phenotypic_feature 1292 1299	obesity
T29	chemical 1306 1315	potassium
T30	chemical 1331 1348	potassium acetate
T31	chemical 1353 1362	potassium
T32	chemical 1371 1378	mixture
T33	chemical 1394 1402	antigens
T34	disease_or_phenotypic_feature 1406 1426	colorectal carcinoma
T35	disease_or_phenotypic_feature 1431 1452	neuroendocrine tumors
T36	chemical 1466 1481	aptamer/protein
T37	chemical 1594 1605	enzyme-free
T38	disease_or_phenotypic_feature 1610 1619	sensitive
T39	chemical 1662 1671	Metformin
T40	chemical 1677 1681	drug
T41	disease_or_phenotypic_feature 1716 1731	type 2 diabetes
T42	disease_or_phenotypic_feature 1733 1740	obesity
T43	chemical 1755 1762	glucose
T44	disease_or_phenotypic_feature 1774 1788	Heart diseases
T45	disease_or_phenotypic_feature 1790 1797	obesity
T46	chemical 1799 1807	nicotine
T47	chemical 1812 1819	alcohol
T48	chemical 1990 2005	oxygen-carrying
T49	disease_or_phenotypic_feature 2027 2032	blood
T50	chemical 2092 2102	Decitabine
T51	chemical 2128 2137	inhibitor
T52	disease_or_phenotypic_feature 2186 2210	hematologic malignancies
T53	chemical 2308 2325	cisplatin-induced
T54	disease_or_phenotypic_feature 2383 2395	hearing loss
T55	chemical 2492 2499	mixture
T56	chemical 2513 2521	iturin A
T57	disease_or_phenotypic_feature 2580 2587	disease
T58	chemical 2677 2685	antigens
T59	disease_or_phenotypic_feature 2697 2711	lung carcinoma
T60	chemical 2742 2748	peanut
T61	chemical 2810 2817	radical
T62	disease_or_phenotypic_feature 2846 2861	cervical cancer
T63	chemical 2879 2887	adjuvant
T64	chemical 2998 3003	label
T65	chemical 3013 3023	olanzapine
T66	disease_or_phenotypic_feature 3041 3073	pervasive developmental disorder
T67	chemical 3098 3106	busulfan
T68	disease_or_phenotypic_feature 3188 3203	aplastic anemia
T69	corrected_chemical 313 351	surfactant-shelled oxygen microbubbles
R1	treats Arg1:T69 Arg2:T86	
T70	missed_chemical 1199 1206	hirudin
R2	treats Arg1:T70 Arg2:T27	
T71	missed_disease_or_phenotypic_feature 1216 1237	neurological deficits
R3	treats Arg1:T70 Arg2:T71	
T72	corrected_chemical 1179 1197	thrombin inhibitor
R4	treats Arg1:T72 Arg2:T71	
R5	treats Arg1:T72 Arg2:T27	
R6	treats Arg1:T30 Arg2:T28	
T73	corrected_chemical 1353 1370	potassium bromide
R7	treats Arg1:T73 Arg2:T28	
T74	corrected_chemical 1306 1325	potassium-rich diet
R8	treats Arg1:T74 Arg2:T28	
T75	missed_disease_or_phenotypic_feature 1746 1772	impaired glucose tolerance
R9	treats Arg1:T39 Arg2:T41	
R10	treats Arg1:T39 Arg2:T42	
R11	treats Arg1:T39 Arg2:T75	
R12	treats Arg1:T40 Arg2:T41	
R13	treats Arg1:T40 Arg2:T42	
R14	treats Arg1:T40 Arg2:T75	
T76	missed_disease_or_phenotypic_feature 1843 1849	stroke
R15	causes_or_contributes_to Arg1:T46 Arg2:T76	
R16	causes_or_contributes_to Arg1:T47 Arg2:T76	
T77	missed_disease_or_phenotypic_feature 2215 2227	solid tumors
T78	corrected_chemical 2106 2137	DNA methyltransferase inhibitor
T79	missed_disease_or_phenotypic_feature 2326 2337	ototoxicity
T80	missed_disease_or_phenotypic_feature 2571 2587	clubroot disease
T81	missed_chemical 2526 2541	RSM hydrolysate
T82	missed_disease_or_phenotypic_feature 2604 2610	growth
R26	treats Arg1:T65 Arg2:T66	
T83	missed_disease_or_phenotypic_feature 201 217	tumor regression
R28	causes_or_contributes_to Arg1:T4 Arg2:T83	
T84	corrected_chemical 99 106	Melan-A
R29	causes_or_contributes_to Arg1:T84 Arg2:T83	
T85	corrected_chemical 107 135	human melanoma tumor antigen
R30	causes_or_contributes_to Arg1:T85 Arg2:T83	
T86	corrected_disease_or_phenotypic_feature 494 514	breast cancer tumors
T87	corrected_chemical 1331 1378	potassium acetate and potassium bromide mixture
R31	treats Arg1:T87 Arg2:T28	
T88	corrected_chemical 2308 2317	cisplatin
R21	causes_or_contributes_to Arg1:T88 Arg2:T79	
R32	causes_or_contributes_to Arg1:T88 Arg2:T54	
T89	corrected_chemical 2492 2502;2513 2541	mixture of iturin A and RSM hydrolysate
R22	treats Arg1:T89 Arg2:T80	
R23	causes_or_contributes_to Arg1:T89 Arg2:T82	
